ARGX argenx SE

941.27USD858.20 EUR · EBR-0.14%Mkt Cap: 59.19B USDP/E: 34.54

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART fo…